Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

SMMT

Summit Therapeutics (SMMT)

Summit Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SMMT
DateTimeSourceHeadlineSymbolCompany
08/11/20223:11PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SMMTSummit Therapeutics Inc
08/11/20227:00AMGlobeNewswire Inc.Summit Therapeutics Inc Reports Financial Results and Operational Progress for the Second Quarter Ended June 30, 2022NASDAQ:SMMTSummit Therapeutics Inc
08/09/20222:36PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
08/09/202212:37PMGlobeNewswire Inc.Summit Therapeutics Closes Fully-Subscribed $100 Million Rights OfferingNASDAQ:SMMTSummit Therapeutics Inc
08/02/20228:25AMGlobeNewswire Inc.Summit Therapeutics’ Rights Offering Nearing Expiration DateNASDAQ:SMMTSummit Therapeutics Inc
07/26/20223:32PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
07/26/20223:15PMGlobeNewswire Inc.Summit Therapeutics Appoints Dr. Maky Zanganeh as Co-CEO & PresidentNASDAQ:SMMTSummit Therapeutics Inc
07/18/20223:18PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
07/18/20223:05PMGlobeNewswire Inc.Summit Therapeutics Announces Commencement of $100 Million Rights OfferingNASDAQ:SMMTSummit Therapeutics Inc
07/18/20222:50PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:SMMTSummit Therapeutics Inc
07/14/20227:30AMGlobeNewswire Inc.Summit Therapeutics Provides Update on RidinilazoleNASDAQ:SMMTSummit Therapeutics Inc
07/07/20229:26AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:SMMTSummit Therapeutics Inc
06/22/20223:37PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
06/22/20223:30PMGlobeNewswire Inc.Summit Therapeutics Announces $100 Million Rights OfferingNASDAQ:SMMTSummit Therapeutics Inc
06/03/20223:32PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SMMTSummit Therapeutics Inc
06/03/20227:30AMGlobeNewswire Inc.Summit Therapeutics’ Upcoming Annual Shareholders’ MeetingNASDAQ:SMMTSummit Therapeutics Inc
06/02/20224:39PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SMMTSummit Therapeutics Inc
06/01/20223:32PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
06/01/20227:30AMGlobeNewswire Inc.Summit Therapeutics Appoints Ankur Dhingra as Chief Financial OfficerNASDAQ:SMMTSummit Therapeutics Inc
05/11/20223:51PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SMMTSummit Therapeutics Inc
05/11/20223:30PMGlobeNewswire Inc.Summit Therapeutics Inc Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2022NASDAQ:SMMTSummit Therapeutics Inc
04/29/20223:56PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:SMMTSummit Therapeutics Inc
04/26/20223:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SMMTSummit Therapeutics Inc
04/14/20223:13PMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:SMMTSummit Therapeutics Inc
04/06/20224:17PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:SMMTSummit Therapeutics Inc
03/17/20224:17PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:SMMTSummit Therapeutics Inc
03/17/20223:25PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
03/17/20223:14PMGlobeNewswire Inc.Summit Therapeutics Inc Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2021NASDAQ:SMMTSummit Therapeutics Inc
03/11/20223:47PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
02/09/20224:08PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:SMMT